Intellia Therapeutics, INC. (NTLA) SEC Filings — 2025
16 SEC filings for Intellia Therapeutics, INC. (NTLA) in 2025.
Filings
- Intellia Therapeutics, INC. 8-K Filing — 8-K · Nov 10, 2025
- Intellia Narrows Losses, Boosts Revenue on R&D Cuts — 10-Q · Nov 6, 2025
- Intellia Therapeutics Files 8-K — 8-K · Oct 29, 2025
- Intellia Therapeutics Files 8-K — 8-K · Oct 27, 2025
- Intellia Therapeutics Files 8-K — 8-K · Sep 25, 2025
- Intellia's Q2 Loss Widens on Soaring R&D, Revenue Dips 24% — 10-Q · Aug 7, 2025
- Intellia Therapeutics Files 8-K — 8-K · Jun 16, 2025
- Intellia Therapeutics Files 8-K on Officer/Director Changes & Shareholder Votes — 8-K · Jun 12, 2025
- Intellia Therapeutics Files 8-K — 8-K · May 28, 2025
- Intellia Therapeutics Files 8-K — 8-K · May 19, 2025
- Intellia Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
- Intellia Therapeutics Executive Compensation Details Released — DEF 14A · Apr 30, 2025
- Intellia Therapeutics Files 8-K with Bylaw Amendments — 8-K · Apr 7, 2025
- Intellia Therapeutics Files 2024 10-K — 10-K · Feb 27, 2025
- Intellia Therapeutics Enters Material Definitive Agreement — 8-K · Feb 21, 2025
- Intellia Therapeutics Files 8-K — 8-K · Jan 10, 2025